Baricitinib (Olumiant) 4 mg is a prescription oral medication classified as a Janus kinase (JAK) inhibitor. It is used to treat autoimmune and inflammatory diseases by regulating the immune system's response. By reducing inflammation, baricitinib helps relieve symptoms such as joint pain, swelling, and stiffness.
This medication is typically prescribed to patients with moderate to severe rheumatoid arthritis and other immune-mediated diseases.
Baricitinib selectively inhibits Janus kinase (JAK) enzymes involved in intracellular signaling pathways of the immune system. By blocking these pathways, the drug reduces the production of inflammatory cytokines, thereby helping to control excessive immune activity and inflammation.
Indications
Baricitinib 4 mg may be prescribed for:
Rheumatoid arthritis
Atopic dermatitis
Other autoimmune or inflammatory diseases as prescribed by a doctor
Dosage and Administration
Recommended dose: 4 mg once daily
Direction: Oral
Use only as directed by a doctor
Do not adjust the dosage without consulting a doctor.
Contraindications
Do not use baricitinib if:
You have a known hypersensitivity to the active substance
You have active or severe infections
Consult a doctor before starting treatment.
Possible Side Effects
Common side effects include:
Upper respiratory tract infections
Headache
Nausea
Increased susceptibility to infections
Seek medical attention if serious adverse reactions occur.
Storage Instructions
Store at room temperature
Keep away from moisture and direct sunlight
Keep out of reach of children
Frequently Asked Questions
What is baricitinib used for? Baricitinib is used to treat autoimmune diseases, such as rheumatoid arthritis, by reducing inflammation and immune system activity.
How quickly does Olumiant work?
Some patients may experience improvement within a few weeks, although it may take longer to achieve the full therapeutic effect.
Is baricitinib safe?
Generally, it is considered safe when used under a doctor's supervision and as directed.
Additional Information
Baricitinib belongs to a class of targeted medications designed to modulate immune system pathways. It is important to follow your doctor's recommendations and be monitored during treatment to ensure safety and effectiveness. Medical Disclaimer
This content is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication.
Ask a question or inquire about delivery to your country